{"id":5172,"date":"2024-06-10T14:12:44","date_gmt":"2024-06-10T06:12:44","guid":{"rendered":"https:\/\/regask.com\/?p=5172"},"modified":"2024-11-05T20:57:03","modified_gmt":"2024-11-05T12:57:03","slug":"%e3%83%81%e3%82%af%e3%83%b3%e3%82%b0%e3%83%8b%e3%82%a2%e7%86%b1%e3%83%af%e3%82%af%e3%83%81%e3%83%b3%e3%81%8c%e6%89%bf%e8%aa%8d","status":"publish","type":"post","link":"https:\/\/regask.com\/ja\/chikungunya-vaccine-approved\/","title":{"rendered":"EMA \u304c\u4fdd\u8b77\u306e\u305f\u3081\u306e\u521d\u306e\u30ef\u30af\u30c1\u30f3\u306e\u627f\u8a8d\u3092\u63a8\u5968"},"content":{"rendered":"<p>2024\u5e745\u670831\u65e5\u3001\u6b27\u5dde\u533b\u85ac\u54c1\u5e81\uff08EMA\uff09\u306f\u3001\u611f\u67d3\u3057\u305f\u868a\u306b\u3088\u3063\u3066\u5a92\u4ecb\u3055\u308c\u308b\u30a6\u30a4\u30eb\u30b9\u6027\u75be\u60a3\u3067\u3042\u308b\u30c1\u30af\u30f3\u30b0\u30cb\u30a2\u71b1\u304b\u3089\u6210\u4eba\u3092\u5b88\u308b\u305f\u3081\u306b\u8a2d\u8a08\u3055\u308c\u305f\u521d\u306e\u30ef\u30af\u30c1\u30f3\u3067\u3042\u308bIxchiq\u306e\u627f\u8a8d\u3092\u63a8\u5968\u3059\u308b\u3068\u767a\u8868\u3057\u305f\u3002<\/p>\n<p>\u30c1\u30af\u30f3\u30b0\u30cb\u30a2\u71b1\u306f\u6025\u901f\u306b\u5e83\u304c\u308a\u3001\u6fc0\u3057\u3044\u95a2\u7bc0\u75db\u3092\u5f15\u304d\u8d77\u3053\u3059\u3053\u3068\u304b\u3089\u61f8\u5ff5\u304c\u9ad8\u307e\u3063\u3066\u304a\u308a\u3001\u3053\u306e\u753b\u671f\u7684\u306a\u958b\u767a\u306f\u516c\u8846\u885b\u751f\u306b\u304a\u3051\u308b\u91cd\u8981\u306a\u7bc0\u76ee\u3068\u306a\u308b\u3002Ixchiq \u306e\u627f\u8a8d\u306f\u3001\u3053\u306e\u8870\u5f31\u6027\u75be\u60a3\u306e\u8513\u5ef6\u3068\u95d8\u3046\u3053\u3068\u3092\u76ee\u6307\u3059\u88fd\u85ac\u304a\u3088\u3073\u30d8\u30eb\u30b9\u30b1\u30a2\u5206\u91ce\u306b\u304a\u3051\u308b\u65b0\u305f\u306a\u7bc0\u76ee\u3068\u306a\u308b\u3002<\/p>\n<p><strong>\u4e3b\u306a\u30cf\u30a4\u30e9\u30a4\u30c8:<\/strong><\/p>\n<ul>\n<li><strong>\u5bfe\u8c61\u8005:<\/strong> \u3053\u306e\u30ef\u30af\u30c1\u30f3\u306f\u3001\u30c1\u30af\u30f3\u30b0\u30cb\u30a2\u71b1\u306b\u611f\u67d3\u3059\u308b\u30ea\u30b9\u30af\u306e\u3042\u308b\u4eba\u53e3\u5c64\u306b\u7126\u70b9\u3092\u5f53\u3066\u3001\u6210\u4eba\u3078\u306e\u4f7f\u7528\u304c\u627f\u8a8d\u3055\u308c\u3066\u3044\u308b\u3002<\/li>\n<li><strong>\u4e16\u754c\u3078\u306e\u5f71\u97ff:<\/strong> \u3053\u306e\u627f\u8a8d\u306f\u3001\u4e16\u754c\u4e2d\u3067\u6d41\u884c\u3057\u3066\u3044\u308b\u75c5\u6c17\u306b\u5bfe\u3059\u308b\u91cd\u8981\u306a\u4e88\u9632\u63aa\u7f6e\u3092\u5c0e\u5165\u3059\u308b\u3082\u306e\u3067\u3042\u308a\u3001\u75c5\u6c17\u306e\u5236\u5fa1\u3068\u4e88\u9632\u306b\u304a\u3051\u308b\u30ef\u30af\u30c1\u30f3\u63a5\u7a2e\u306e\u91cd\u8981\u306a\u5f79\u5272\u3092\u6d6e\u304d\u5f6b\u308a\u306b\u3057\u3066\u3044\u307e\u3059\u3002<\/li>\n<li><strong>\u696d\u754c\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9:<\/strong> \u30ef\u30af\u30c1\u30f3\u306e\u88fd\u9020\u3001\u6d41\u901a\u3001\u307e\u305f\u306f\u6295\u4e0e\u306b\u643a\u308f\u308b\u4f01\u696d\u306f\u3001\u3053\u306e\u65b0\u3057\u3044\u30ef\u30af\u30c1\u30f3\u3092\u7d44\u307f\u8fbc\u3080\u305f\u3081\u306b\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3068\u898f\u5236\u306e\u67a0\u7d44\u307f\u3092\u66f4\u65b0\u3057\u3001EMA \u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306b\u6e96\u62e0\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/li>\n<li><strong>\u30d8\u30eb\u30b9\u30b1\u30a2\u30ac\u30a4\u30c0\u30f3\u30b9:<\/strong> \u63d0\u4f9b\u8005\u3068\u898f\u5236\u30c1\u30fc\u30e0\u306f\u3001\u30ef\u30af\u30c1\u30f3\u306e\u5165\u624b\u53ef\u80fd\u6027\u3001\u63a8\u5968\u3055\u308c\u308b\u4f7f\u7528\u65b9\u6cd5\u3001\u304a\u3088\u3073\u30ef\u30af\u30c1\u30f3\u63a5\u7a2e\u30b9\u30b1\u30b8\u30e5\u30fc\u30eb\u306e\u6f5c\u5728\u7684\u306a\u66f4\u65b0\u306b\u3064\u3044\u3066\u5e38\u306b\u60c5\u5831\u3092\u5165\u624b\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/li>\n<li><strong>\u7d99\u7d9a\u7684\u306a\u76e3\u8996:<\/strong> \u9032\u884c\u4e2d\u306e\u7814\u7a76\u304c\u898f\u5236\u57fa\u6e96\u306b\u5f71\u97ff\u3092\u53ca\u307c\u3059\u53ef\u80fd\u6027\u304c\u3042\u308b\u305f\u3081\u3001\u898f\u5236\u30c1\u30fc\u30e0\u306f\u30ef\u30af\u30c1\u30f3\u306e\u6709\u52b9\u6027\u3068\u5b89\u5168\u6027\u306b\u95a2\u3059\u308b\u3055\u3089\u306a\u308b\u7814\u7a76\u3084\u6700\u65b0\u60c5\u5831\u3092\u76e3\u8996\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/li>\n<\/ul>\n<p>\u3053\u306e\u610f\u898b\u306f\u4eca\u5f8c\u3001EU \u5168\u57df\u3067\u306e\u8ca9\u58f2\u627f\u8a8d\u306e\u6c7a\u5b9a\u3092\u63a1\u629e\u3059\u308b\u305f\u3081\u306b\u6b27\u5dde\u59d4\u54e1\u4f1a\u306b\u9001\u3089\u308c\u308b\u4e88\u5b9a\u3067\u3059\u3002Ixchiq \u306e\u7533\u8acb\u8005\u306f Valneva Austria GmbH \u3067\u3059\u3002<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<a data-animate=\"fadeInLeft\" href=\"https:\/\/www.ema.europa.eu\/en\/news\/first-vaccine-protect-adults-chikungunya\" target=\"_blank\" class=\"button secondary is-link is-medium\" rel=\"noopener\" >\n\t\t<span>\u8a18\u4e8b\u5168\u6587\u3092\u8aad\u3080<\/span>\n\t<\/a>\n\n<p>\u00a9\u3053\u306eRegAlert\u306fRegASK\u306b\u3088\u3063\u3066\u767a\u884c\u3055\u308c\u3066\u3044\u307e\u3059<\/p>","protected":false},"excerpt":{"rendered":"<p>On May 31, 2024, the European Medicines Agency (EMA) announced its recommendation for the approval of Ixchiq, the first vaccine designed to protect adults against chikungunya, a viral disease transmitted by infected mosquitoes. This groundbreaking development marks a significant milestone in public health, as chikungunya has been a growing concern due to its rapid spread and the severe joint pain it causes. The approval of Ixchiq represents a new milestone in the pharmaceutical and healthcare sectors, aiming to combat the spread of this debilitating disease. Key Highlights: Target Audience: The vaccine has been authorized for use in adults, focusing on a demographic at risk of contracting chikungunya. Global Impact: This&#8230;<\/p>","protected":false},"author":39,"featured_media":3960,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[35],"tags":[247,419,421,423,425],"class_list":["post-5172","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-biotech-latest-insights","tag-regulation-eu-legislation","tag-vaccine","tag-chikungunya","tag-ema","tag-market-authorization"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Chikungunya Vaccine Approved by EMA | RegASK<\/title>\n<meta name=\"description\" content=\"EMA recommends approval of Ixchiq, the first vaccine to protect adults against chikungunya. Learn more about this breakthrough.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/ja\/\u30c1\u30af\u30f3\u30b0\u30cb\u30a2\u71b1\u30ef\u30af\u30c1\u30f3\u304c\u627f\u8a8d\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EMA Recommends Approval of the First Vaccine to Protect Adults Against Chikungunya\" \/>\n<meta property=\"og:description\" content=\"EMA recommends approval of Ixchiq, the first vaccine to protect adults against chikungunya. Learn more about this breakthrough.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/ja\/\u30c1\u30af\u30f3\u30b0\u30cb\u30a2\u71b1\u30ef\u30af\u30c1\u30f3\u304c\u627f\u8a8d\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-10T06:12:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-05T12:57:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya-870x653.png\" \/>\n\t<meta property=\"og:image:width\" content=\"870\" \/>\n\t<meta property=\"og:image:height\" content=\"653\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"EMA Recommends Approval of the First Vaccine to Protect&hellip;\",\"datePublished\":\"2024-06-10T06:12:44+00:00\",\"dateModified\":\"2024-11-05T12:57:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/\"},\"wordCount\":282,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png\",\"keywords\":[\"Regulation EU Legislation\",\"Vaccine\",\"Chikungunya\",\"EMA\",\"Market Authorization\"],\"articleSection\":[\"Pharma and Biotech\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/\",\"name\":\"Chikungunya Vaccine Approved by EMA | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png\",\"datePublished\":\"2024-06-10T06:12:44+00:00\",\"dateModified\":\"2024-11-05T12:57:03+00:00\",\"description\":\"EMA recommends approval of Ixchiq, the first vaccine to protect adults against chikungunya. Learn more about this breakthrough.\",\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/regask.com\\\/chikungunya-vaccine-approved\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png\",\"width\":1600,\"height\":1200,\"caption\":\"New Vaccine To Protect People In The Eu And Worldwide Against Dengue\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u30c1\u30af\u30f3\u30b0\u30cb\u30a2\u71b1\u30ef\u30af\u30c1\u30f3\u304cEMA\u306b\u3088\u308a\u627f\u8a8d | RegASK","description":"EMA \u306f\u3001\u6210\u4eba\u3092\u30c1\u30af\u30f3\u30b0\u30cb\u30a2\u71b1\u304b\u3089\u5b88\u308b\u521d\u306e\u30ef\u30af\u30c1\u30f3\u3067\u3042\u308b Ixchiq \u306e\u627f\u8a8d\u3092\u63a8\u5968\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u753b\u671f\u7684\u306a\u30ef\u30af\u30c1\u30f3\u306b\u3064\u3044\u3066\u8a73\u3057\u304f\u3054\u89a7\u304f\u3060\u3055\u3044\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/ja\/\u30c1\u30af\u30f3\u30b0\u30cb\u30a2\u71b1\u30ef\u30af\u30c1\u30f3\u304c\u627f\u8a8d\/","og_locale":"ja_JP","og_type":"article","og_title":"EMA Recommends Approval of the First Vaccine to Protect Adults Against Chikungunya","og_description":"EMA recommends approval of Ixchiq, the first vaccine to protect adults against chikungunya. Learn more about this breakthrough.","og_url":"https:\/\/regask.com\/ja\/\u30c1\u30af\u30f3\u30b0\u30cb\u30a2\u71b1\u30ef\u30af\u30c1\u30f3\u304c\u627f\u8a8d\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2024-06-10T06:12:44+00:00","article_modified_time":"2024-11-05T12:57:03+00:00","og_image":[{"width":870,"height":653,"url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya-870x653.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"\u57f7\u7b46\u8005":"Benoit Trouwaert","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/chikungunya-vaccine-approved\/#article","isPartOf":{"@id":"https:\/\/regask.com\/chikungunya-vaccine-approved\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"EMA Recommends Approval of the First Vaccine to Protect&hellip;","datePublished":"2024-06-10T06:12:44+00:00","dateModified":"2024-11-05T12:57:03+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/chikungunya-vaccine-approved\/"},"wordCount":282,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/chikungunya-vaccine-approved\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png","keywords":["Regulation EU Legislation","Vaccine","Chikungunya","EMA","Market Authorization"],"articleSection":["Pharma and Biotech"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/regask.com\/chikungunya-vaccine-approved\/","url":"https:\/\/regask.com\/chikungunya-vaccine-approved\/","name":"\u30c1\u30af\u30f3\u30b0\u30cb\u30a2\u71b1\u30ef\u30af\u30c1\u30f3\u304cEMA\u306b\u3088\u308a\u627f\u8a8d | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/chikungunya-vaccine-approved\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/chikungunya-vaccine-approved\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png","datePublished":"2024-06-10T06:12:44+00:00","dateModified":"2024-11-05T12:57:03+00:00","description":"EMA \u306f\u3001\u6210\u4eba\u3092\u30c1\u30af\u30f3\u30b0\u30cb\u30a2\u71b1\u304b\u3089\u5b88\u308b\u521d\u306e\u30ef\u30af\u30c1\u30f3\u3067\u3042\u308b Ixchiq \u306e\u627f\u8a8d\u3092\u63a8\u5968\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u753b\u671f\u7684\u306a\u30ef\u30af\u30c1\u30f3\u306b\u3064\u3044\u3066\u8a73\u3057\u304f\u3054\u89a7\u304f\u3060\u3055\u3044\u3002","inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/chikungunya-vaccine-approved\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/regask.com\/chikungunya-vaccine-approved\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png","width":1600,"height":1200,"caption":"New Vaccine To Protect People In The Eu And Worldwide Against Dengue"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"\u3088\u308a\u30b9\u30de\u30fc\u30c8\u306a\u898f\u5236\u6c7a\u5b9a\u3092\u4fc3\u9032","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd"]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"\u30d6\u30ce\u30ef\u30fb\u30c8\u30a5\u30eb\u30ef\u30fc\u30eb"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/posts\/5172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/comments?post=5172"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/posts\/5172\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/media\/3960"}],"wp:attachment":[{"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/media?parent=5172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/categories?post=5172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/tags?post=5172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}